Abstract:Retinoic acid inducible-gene I (RIG-I) detects short dsRNA and stem-loop RNA species bearing a 5'-triphosphate end, and functions as one of the major sensors of RNA viruses (Myong, Cui et al., 2009, Pichlmair, Schulz et al., 2006). DDX58, which encodes the RIG-I protein has been newly identified as a susceptibility gene in psoriasis, a chronic inflammatory skin disorder affecting the skin in 1-3% of the general population (2009, Tsoi, Spain et al., 2012). Recently, interleukin (IL)-23 has been demonstrated as a key master cytokine that promotes T helper 17 (Th17) cell survival and proliferation, and targeting the IL-23p19 subunit with a monoclonal antibody results in the clinical improvement in psoriasis (Kopp, Riedl et al., 2015, Zheng, Danilenko et al., 2007). Yet what triggers IL-23 production in the skin of individuals genetically predisposed to develop psoriasis is still unclear. Here, we show that RIG-I expression is increased in the affected skin derived from psoriasis patients and from IL-23-induced mouse model of psoriasis. The activation of RIG-I by 5'ppp-dsRNA, its synthetic ligand, directly causes the production of IL-23 and promotes chronic cutaneous inflammation in mice that closely resembles human psoriasis. Repeated injections of IL-23 to the ears failed to induce IL-23 production and a full psoriasiform skin phenotype, both in germ-free and RIG-I knockout mice. Furthermore, RIG-I-mediated IL-23 production was confined to the CD11c+ myeloid dendritic cells (mDCs) via nuclear factor-kappa B (NF-κB) signaling, and stimulated RIG-I expression in an auto-regulatory feedback loop. Thus, our data suggest that the RIG-I-mediated antiviral response is pivotal for the local IL-23 production in the mDCs and for the IL-23-induced psoriasiform skin inflammation in mice, supporting the notion that dysregulation in the antiviral immune responses of hosts through the innate pattern-recognition receptors may trigger the skin inflammatory conditions in the pathophysiology of psoriasis.

Epigenetic Regulation of IL-23 by E3 Ligase FBXW7 in Dendritic Cells is Critical for Psoriasis-like Inflammation.

Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation

UBE2L3 Reduces TRIM21 Expression and IL-1β Secretion in Epidermal Keratinocytes and Improves Psoriasis-Like Skin

FXYD3 enhances IL-17A signaling to promote psoriasis by competitively binding TRAF3 in keratinocytes

CCR7 DC Define a Type 17 Module in Psoriasis

443 EZH2-dependent Epigenetic Modulation of Histone H3 Lysine-27 Contributes to Psoriasis by Promoting Keratinocyte Proliferation

Epidermal CD147 expression plays a key role in IL-22-induced psoriatic dermatitis

E3 ligase FBXW7 aggravates TMPD-induced systemic lupus erythematosus by promoting cell apoptosis

EZH2-dependent epigenetic modulation of histone H3 lysine-27 contributes to psoriasis by promoting keratinocyte proliferation

IL-6 Up-Regulates Expression of LIM-Domain Only Protein 4 in Psoriatic Keratinocytes through Activation of the MEK/ERK/NF-κB Pathway

IL-23 induces CLEC5A+ IL-17A+ neutrophils and elicit skin inflammation associated with psoriatic arthritis

SIRT3 alleviates imiquimod-induced psoriatic dermatitis through deacetylation of XBP1s and modulation of TLR7/8 inducing IL-23 production in macrophages

Inducible nitric oxide synthase-expressing myeloid-derived suppressor cells regulated by interleukin 35 contribute to the pathogenesis of psoriasis

RNA-seq reveal RNA binding protein GNL3 as a key mediator in the development of psoriasis vulgaris by regulating the IL23/IL17 axis

Human IL-23R Cytokine-Binding Homology Region-Fc Fusion Protein Ameliorates Psoriasis via the Decrease of Systemic Th17 and ILC3 Cell Responses

Negative regulation of dendritic cell activation in psoriasis mediated via CD100-Plexin-B2.

Abnormal lipid metabolism in epidermal Langerhans cells mediates psoriasis-like dermatitis

An Autocrine Circuit of IL-33 in Keratinocytes Is Involved in the Progression of Psoriasis

Synergistic Induction of IL-23 by TNFα, IL-17A, and EGF in Keratinocytes.

592 RIG-I Antiviral Signaling Drives Interleukin-23 Production and Psoriasis-Like Skin Disease

IL23R mutations associated with decreased risk of psoriasis lead to the differential expression of genes implicated in the disease